Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1990 | 1 |
| 1991 | 2 |
| 1992 | 4 |
| 1994 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2015 | 2 |
| 2024 | 0 |
Search Results
15 results
Results by year
Page 1
A modified extravesical technique for megaureter repair.
Br J Urol. 1994 Dec;74(6):715-9. doi: 10.1111/j.1464-410x.1994.tb07112.x.
Br J Urol. 1994.
PMID: 7827839
Effect of dutasteride on the risk of prostate cancer.
N Engl J Med. 2010 Apr 1;362(13):1192-202. doi: 10.1056/NEJMoa0908127.
N Engl J Med. 2010.
PMID: 20357281
Free article.
Clinical Trial.
Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
N Engl J Med. 2009 Aug 20;361(8):745-55. doi: 10.1056/NEJMoa0809003. Epub 2009 Aug 11.
N Engl J Med. 2009.
PMID: 19671656
Free PMC article.
Clinical Trial.
Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.
Cancer Res. 2004 Sep 1;64(17):5929-33. doi: 10.1158/0008-5472.CAN-04-1216.
Cancer Res. 2004.
PMID: 15342369
Penile amputation and successful reattachment and the role of winter shunt in postoperative viability: A case report and literature review.
Can Urol Assoc J. 2015 May-Jun;9(5-6):E297-9. doi: 10.5489/cuaj.2522.
Can Urol Assoc J. 2015.
PMID: 26029299
Free PMC article.
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial.
Lancet Oncol. 2015 Mar;16(3):338-48. doi: 10.1016/S1470-2045(15)70027-6. Epub 2015 Feb 18.
Lancet Oncol. 2015.
PMID: 25701170
Clinical Trial.
Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
Prostate. 2009 Jun 15;69(9):961-75. doi: 10.1002/pros.20949.
Prostate. 2009.
PMID: 19267368
Omeprazole in post-gastrocystoplasty metabolic alkalosis and aciduria.
J Urol. 1992 Feb;147(2):435-7. doi: 10.1016/s0022-5347(17)37261-0.
J Urol. 1992.
PMID: 1732611
A 1-year, open label, randomized phase II dose finding study of degarelix for the treatment of prostate cancer in North America.
J Urol. 2008 Nov;180(5):1986-92. doi: 10.1016/j.juro.2008.07.033. Epub 2008 Sep 17.
J Urol. 2008.
PMID: 18801505
Clinical Trial.
Cite